Meet Dr. Simos Kedikoglou, President and COO at Anumana. A physician by training with two decades of medtech leadership, including CEO of Impulse Dynamics and Corporate VP of Business Development at Boston Scientific, Simos now leads the operational strategy behind scaling health systems.
#MeetTheTeam #CardiacAI #TeamAnumana
#MeetTheTeam #CardiacAI #TeamAnumana
0
0
0
76
We'll be at CVLink 2026 in Atlanta, Oct 16–17, connecting with physicians and leaders on where point-of-care AI, like ECG-AI®, fits into the future of cardiovascular care.
Visit anumana.ai and cvlei.org to learn more.
#CVLink2026 #CardiacAI
Visit anumana.ai and cvlei.org to learn more.
#CVLink2026 #CardiacAI
0
0
0
40
Anumana's Samir Awasthi will speak at @MayoClinic's Current Applications and Future of AI in Cardiology meeting, Oct. 11–14, in Napa, CA, in "An Evening with AI Companies Who Have a Cardiology Focus – Journey from Idea to Implementation."
#AIinCardiology26 #CardiacAI
#AIinCardiology26 #CardiacAI
0
0
0
37
Many cases of cardiac arrest show no warning signs, but risk signals can sometimes hide in the routine ECG.
This month, Anumana recognizes Sudden Cardiac Arrest Awareness Month by bringing ECG-AI®to more patients at the point of care.
#SCAAwarenessMonth #CardiacAI
sca-aware.org/sca-news/octob…
This month, Anumana recognizes Sudden Cardiac Arrest Awareness Month by bringing ECG-AI®to more patients at the point of care.
#SCAAwarenessMonth #CardiacAI
sca-aware.org/sca-news/octob…
0
0
0
33
We recently attended Challenges in Clinical Cardiology: A Case-Based Update, held Oct. 2–4 in Chicago, where we connected with industry experts to discuss how ECG-AI® brings deeper insights to the point of care.
#ChallengesInClinicalCardiology #CardiacAI
cveducation.mayo.edu/store/challeng…
#ChallengesInClinicalCardiology #CardiacAI
cveducation.mayo.edu/store/challeng…
0
0
0
38
Meet Wui Ip, MD, Senior Medical Director at Anumana.
A Harvard Medical School graduate and Stanford-trained physician informaticist, Wui is now applying his expertise to evidence-backed cardiac intelligence and AI-enabled clinical workflows.
#MeetTheTeam #CardiacAI #TeamAnumana
A Harvard Medical School graduate and Stanford-trained physician informaticist, Wui is now applying his expertise to evidence-backed cardiac intelligence and AI-enabled clinical workflows.
#MeetTheTeam #CardiacAI #TeamAnumana
0
0
0
93
Anumana is attending the Cleveland Clinic Global EP Summit on September 18. We’d love to connect. anumana.ai
#GlobalEPSummit #Electrophysiology #CardiacAI
clevelandclinicmeded.com/live/courses/g…
#GlobalEPSummit #Electrophysiology #CardiacAI
clevelandclinicmeded.com/live/courses/g…
0
0
0
42
The real challenge isn't proving ECG-AI® works. It's bringing point-of-care diagnostics into everyday practice, for every patient.
Anumana's Samir Awasthi joins electrophysiologists and health system leaders from Duke, Baylor Scott & White, Honor Health, and UT Southwestern for a roHRX 2026, Sept. 19.
Our founder Murali Aravamudan (also co-founder and CEO of nference) takes the Main Stage on Sept. 18 alongside Duke's Dr. Jonathan Piccini.
#HRX2026 #Electrophysiology #DigitalHealth
@experienceHRX
Anumana's Samir Awasthi joins electrophysiologists and health system leaders from Duke, Baylor Scott & White, Honor Health, and UT Southwestern for a roHRX 2026, Sept. 19.
Our founder Murali Aravamudan (also co-founder and CEO of nference) takes the Main Stage on Sept. 18 alongside Duke's Dr. Jonathan Piccini.
#HRX2026 #Electrophysiology #DigitalHealth
@experienceHRX
0
1
1
208
We’re proud to partner with the ACC Quality Summit as an exhibitor and support the conference planning team in recognizing the leadership driving quality improvement and innovation in cardiovascular care.
We look forward to connecting with the ACC Quality Summit Program ees.
@ACCinTouch
#ACCQuality26
We look forward to connecting with the ACC Quality Summit Program ees.
@ACCinTouch
#ACCQuality26
0
0
0
40
We’re at the Becker’s Health IT + Digital Health + Revenue Cycle Conference, Sept. 14–16. Come see us at booth #5114 to learn more about our point-of-care cardiovascular disease detection solutions. Visit anumana.ai to learn more.
#DigitalHealth #HealthIT #HITRCM26
#DigitalHealth #HealthIT #HITRCM26
0
0
0
36
Meet Dr. Samir Awasthi, VP of Clinical Research at Anumana.
MIT physics. An MD-PhD in biophotonics. A career translating science into clinical practice.
Today, he leads the clinical research helping advance AI-enabled approaches to cardiac care, with a focus on building the g these technologies into practice.
#MeetTheTeam #Cardiology #AIinHealthcare
MIT physics. An MD-PhD in biophotonics. A career translating science into clinical practice.
Today, he leads the clinical research helping advance AI-enabled approaches to cardiac care, with a focus on building the g these technologies into practice.
#MeetTheTeam #Cardiology #AIinHealthcare
0
1
1
110
Arizona Heart & Vascular Clinic is now running Anumana’s full ECG-AI® portfolio in routine clinical care.
One routine ECG. Multiple FDA-cleared algorithms. Expanded support for earlier detection of low ejection fraction, cardiac amyloidosis, and pulmonary hypertension (mPAP) in theiat anumana.ai, and for important safety information and indications, visit anumana.ai/ecg-ai-indicat….
#Cardiology #AIinHealthcare #DigitalHealth
@azheartvascular
One routine ECG. Multiple FDA-cleared algorithms. Expanded support for earlier detection of low ejection fraction, cardiac amyloidosis, and pulmonary hypertension (mPAP) in theiat anumana.ai, and for important safety information and indications, visit anumana.ai/ecg-ai-indicat….
#Cardiology #AIinHealthcare #DigitalHealth
@azheartvascular
0
0
1
55
We’ll be at Cleveland Clinic's State of the Art Topics in the Prevention and Management of Cardiovascular Diseases this week.
Stop by our table to meet the team!
Visit clevelandclinicmeded.com/live/courses/c… for details.
#Cardiology #ArtificialIntelligence #DigitalHealth
Stop by our table to meet the team!
Visit clevelandclinicmeded.com/live/courses/c… for details.
#Cardiology #ArtificialIntelligence #DigitalHealth
0
0
0
70
How can health systems successfully implement AI-enabled ECG in clinical practice?
In the latest @ACCinTouch AI-Enabled Clinician podcast, Dr. @AmiBhattMD and Dr. Faraz Ahmad discuss real-world implementation, clinical workflows, and lessons for clinician leaders.
Listen here: acc.org/Latest-in-Card…
This podcast episode is supported by Anumana.
#Cardiology #DigitalHealth #ECG #HealthcareInnovation
In the latest @ACCinTouch AI-Enabled Clinician podcast, Dr. @AmiBhattMD and Dr. Faraz Ahmad discuss real-world implementation, clinical workflows, and lessons for clinician leaders.
Listen here: acc.org/Latest-in-Card…
This podcast episode is supported by Anumana.
#Cardiology #DigitalHealth #ECG #HealthcareInnovation
0
1
0
105
Anumana has surpassed 300 patents worldwide, including more than 100 patents granted.
This milestone reflects years of innovation across AI-powered cardiovascular care spanning disease detection, clinical decision support, imaging, and procedural technologies.
As AI reshapes building one of the industry's deepest intellectual property portfolios dedicated to cardiovascular medicine.
#HealthcareAI #Cardiology #Innovation
This milestone reflects years of innovation across AI-powered cardiovascular care spanning disease detection, clinical decision support, imaging, and procedural technologies.
As AI reshapes building one of the industry's deepest intellectual property portfolios dedicated to cardiovascular medicine.
#HealthcareAI #Cardiology #Innovation
0
0
1
78
In case you missed it – Anumana's Samir Awasthi in @DAICeditor:
"The value is not in pattern recognition for its own sake. The value is in changing the timing and precision of care."
From validation to workflow integration to downstream planning – a grounded read on what moves ECG-AI® from promise to practice in cardiovascular care.
dicardiology.com/article/turnin…
For important safety information and indications, visit anumana.ai/ecg-ai-indicat….
#Cardiology #HealthcareAI
"The value is not in pattern recognition for its own sake. The value is in changing the timing and precision of care."
From validation to workflow integration to downstream planning – a grounded read on what moves ECG-AI® from promise to practice in cardiovascular care.
dicardiology.com/article/turnin…
For important safety information and indications, visit anumana.ai/ecg-ai-indicat….
#Cardiology #HealthcareAI
0
0
0
74
Thank you, @Forbes, for featuring Anumana and our CEO, Maulik Nanavaty, in this important conversation about the future of cardiac care. At Anumana, we’ve approached this work the same way medicine has always validated new tools – through peer-reviewed research, randomized trials, and a rigorous path to FDA clearance.
The EAGLE trial, published in Nature Medicine, remains one of the largest randomized controlled trials demonstrating the value of AI in routine clinical practice. This year, our algorithms – ECG-AI Pulmonary Hypertension and ECG-AI Cardiac Amyloidosis – were the first of their kind to receive FDA clearance.
Trained on more than 22 million anonymized patient datasets and physician notes spanning 15–20 years, our algorithms were built from the ground up and supported by extensive clinical evidence. That's how AI earns a place at the point of care.
Read the full article here: forbes.com/sites/talpatal…
Anumana devices are not indicated for the diagnosis of any cardiovascular condition. Please refer to the full expansion of the indications for use for Pulmonary Hypertension, e.g., elevated mPAP, indicative of Pulmonary Hypertension in patients with dyspnea. For important safety information and indications, visit anumana.ai/ecg-ai-indicat….
#Cardiology
#AIinHealthcare
#ECGAI
The EAGLE trial, published in Nature Medicine, remains one of the largest randomized controlled trials demonstrating the value of AI in routine clinical practice. This year, our algorithms – ECG-AI Pulmonary Hypertension and ECG-AI Cardiac Amyloidosis – were the first of their kind to receive FDA clearance.
Trained on more than 22 million anonymized patient datasets and physician notes spanning 15–20 years, our algorithms were built from the ground up and supported by extensive clinical evidence. That's how AI earns a place at the point of care.
Read the full article here: forbes.com/sites/talpatal…
Anumana devices are not indicated for the diagnosis of any cardiovascular condition. Please refer to the full expansion of the indications for use for Pulmonary Hypertension, e.g., elevated mPAP, indicative of Pulmonary Hypertension in patients with dyspnea. For important safety information and indications, visit anumana.ai/ecg-ai-indicat….
#Cardiology
#AIinHealthcare
#ECGAI
0
0
1
136
AI won’t change cardiovascular care unless it fits the realities of clinical practice.
In a recent article in @DAICeditor, Dr. Samir Awasthi, VP of Clinical Research at Anumana, explores how AI-enabled ECG can translate underutilized ECG data into actionable clinical insight when implemented thoughtfully.
The opportunity isn’t just better pattern recognition. It’s decision support that helps clinicians:
• Surface potential disease signals earlier in the care pathway
• Prioritize follow-up and confirmatory testing
• Integrate AI insight directly into existing workflows
• Support more informed clinical decision-making without adding burden
As the article outlines, real-world adoption depends on more than algorithm performance. Clinical validation, workflow integration, governance, and downstream operational planning all matter – especially as earlier detection shifts care upstream.
AI-powered ECG surfaces risk already embedded in routine ECG data. The challenge – and the opportunity – is turning that insight into action clinicians can trust.
Read the full article: dicardiology.com/article/turnin…
#HealthcareAI
#Cardiology
#ClinicalAI
#DigitalHealth
#ClinicalDecisionSupport
In a recent article in @DAICeditor, Dr. Samir Awasthi, VP of Clinical Research at Anumana, explores how AI-enabled ECG can translate underutilized ECG data into actionable clinical insight when implemented thoughtfully.
The opportunity isn’t just better pattern recognition. It’s decision support that helps clinicians:
• Surface potential disease signals earlier in the care pathway
• Prioritize follow-up and confirmatory testing
• Integrate AI insight directly into existing workflows
• Support more informed clinical decision-making without adding burden
As the article outlines, real-world adoption depends on more than algorithm performance. Clinical validation, workflow integration, governance, and downstream operational planning all matter – especially as earlier detection shifts care upstream.
AI-powered ECG surfaces risk already embedded in routine ECG data. The challenge – and the opportunity – is turning that insight into action clinicians can trust.
Read the full article: dicardiology.com/article/turnin…
#HealthcareAI
#Cardiology
#ClinicalAI
#DigitalHealth
#ClinicalDecisionSupport
0
0
0
116
Heart failure diagnoses often occur in acute care settings like the emergency room. Not because the disease wasn’t there, but because the tools to catch it weren’t accessible enough to act on.
Our President & COO, Simos Kedikoglou, answered questions from @CardioCareToday on how AI-enabled ECG analysis is changing that equation, detecting early signs of heart failure using a 12-lead ECG available in virtually any care setting.
Watch the full Q&A to hear what that means for patients and the clinicians who serve them: cardiocaretoday.com/post/ai-unlock…
#Cardiology #AIinHealthcare #DigitalHealth #MedTech #ClinicalInnovation
Anumana devices are not indicated for the diagnosis of any cardiovascular condition. Please refer to the full expansion of the indications for use for Pulmonary Hypertension, e.g., elevated mPAP, indicative of Pulmonary Hypertension in patients with dyspnea. For important safety information and indications, visit anumana.ai/ecg-ai-pulmona…
Our President & COO, Simos Kedikoglou, answered questions from @CardioCareToday on how AI-enabled ECG analysis is changing that equation, detecting early signs of heart failure using a 12-lead ECG available in virtually any care setting.
Watch the full Q&A to hear what that means for patients and the clinicians who serve them: cardiocaretoday.com/post/ai-unlock…
#Cardiology #AIinHealthcare #DigitalHealth #MedTech #ClinicalInnovation
Anumana devices are not indicated for the diagnosis of any cardiovascular condition. Please refer to the full expansion of the indications for use for Pulmonary Hypertension, e.g., elevated mPAP, indicative of Pulmonary Hypertension in patients with dyspnea. For important safety information and indications, visit anumana.ai/ecg-ai-pulmona…
0
0
0
48
It was a pleasure to participate in the Mayo Clinic Cardiology & Radiology Innovation Summit last week.
Our CEO, Maulik Nanavaty, joined leaders from across healthcare to discuss what it takes to bring meaningful innovation into clinical practice, the partnerships that make it possith @MayoClinic shapes the journey.
Our CEO, Maulik Nanavaty, joined leaders from across healthcare to discuss what it takes to bring meaningful innovation into clinical practice, the partnerships that make it possith @MayoClinic shapes the journey.
0
0
1
63